Q1Medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource

June 2022 Medicare Drug List Updates: Seventy-five (75) medications added to the 2022 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Jun, 17 2022 08:06:53
< Previous
Next >
The June 2022 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The June formulary updates include the addition of 75 new National Drug Codes (NDCs), representing 46 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the June 2022 Formulary updates include seven (7) newly-added brand-name drugs

The June drug data updates include nineteen (19) new brand-name drugs, seven (7) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • FLEQSUVY®,
  • IBSRELA®,
  • LOFENA®,
  • PHEXXI®,
  • PYRUKYND®,
  • SOAANZ®,
  • ZEGALOGUE®,

The June 2022 Formulary updates include ten (10) newly-added generic drugs

The June Medicare Part D drug data also includes twenty-seven (27) new generic medications, ten (10) of which are newly-introduced generic drugs.  These new generic drugs include:
  • APOMORPHINE [Apokyn®],
  • BETAINE [Cystadane®],
  • CROTAN [Eurax®],
  • DEXAMETHASONE [Decadron®],
  • DICLOFENAC [Zipsor®],
  • ERYTHROMYCIN-BENZOYL [Benzamycin®],
  • FLURANDRENOLIDE [Nolix®],
  • GLYCOPYRROLATE [Glycate®],
  • LACOSAMIDE [Vimpat®], and
  • LENALIDOMIDE [Revlimid®].

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html


Summary of June 2022 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 75 new June 2022 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form and Strength 1
New Drug 23
New Drug and Strength 35
New Drug, Delivery Form and Strength 2
New Manufacturer 2
New Manufacturer and Strength 5
New Packaging 4
New Strength 3
Grand Total 75

The following chart details the 75 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
00023350731 ACUVAIL 0.45% OPHTH SOLUTION DROPERETTE 1 29 New Drug
76204001155 ALBUTEROL SUL 1.25 MG/3 ML SOLUTION VIAL-NEB 59 403 New Manufacturer and Strength
76204001055 ALBUTEROL SUL 0.63 MG/3 ML SOLUTION VIAL-NEB [Accuneb] 59 399 New Drug
00051846212 ANDROGEL 1.62%(1.25G) GEL PACKET 2 1 New Packaging
00051846201 ANDROGEL 1.62%(2.5G) GEL PACKET 2 5 New Packaging
52817072005 APOMORPHINE 30 MG/3 ML CARTRIDGE [Apokyn] 36 184 New Drug
00078072210 AZOPT 1% EYE DROPS/EYE DROPPER 19 125 New Drug
00409083011 AZTREONAM 2 GM VIAL [Azactam] 61 375 New Manufacturer and Strength
72647090001 BETAINE 1 GRAM/SCOOP POWDER [Cystadane] 59 368 New Drug
68047072101 BUTALBITAL-ACETAMINOPHN 50-325 TABLET [Phrenilin] 14 96 New Drug
00093542088 CABERGOLINE 0.5 MG TABLET [Dostinex] 63 403 New Drug
51862085601 CARBIDOPA-LEVODOPA 25-100 TABLET [SINEMET] 63 403 New Manufacturer and Strength
16571068901 CARBIDOPA-LEVODOPA 50 MG-ENTA TABLET [Stalevo] 42 368 New Drug and Strength
16571069001 CARBIDOPA-LEVODOPA 75 MG-ENTA TABLET [Stalevo] 42 368 New Drug and Strength
16571069101 CARBIDOPA-LEVODOPA 100 MG-ENTA TABLET [Stalevo] 42 369 New Drug and Strength
16571069201 CARBIDOPA-LEVODOPA 125 MG-ENTA TABLET [Stalevo] 42 369 New Drug and Strength
16571069301 CARBIDOPA-LEVODOPA 150 MG-ENTA TABLET [Stalevo] 42 369 New Drug and Strength
16571069401 CARBIDOPA-LEVODOPA 200 MG-ENTA TABLET [Stalevo] 42 369 New Drug and Strength
00049204010 CARDURA XL 4 MG TABLET ER 24 0 46 New Strength
51672419303 CLOBETASOL PROP 0.05% FOAM [Olux] 20 173 New Drug
00682005110 CROTAN 10% LOTION [Eurax] 9 60 New Drug
54879000308 DEXAMETHASONE 0.5 MG/5 ML ELIXIR [Decadron] 63 403 New Drug
00054318544 DIAZEPAM 5 MG/ML ORAL CONC 50 382 New Strength
00480943589 DICLOFENAC POTASSIUM 25 MG CAPSULE [Zipsor] 0 5 New Drug
00037605093 EDLUAR 5 MG SUBLIGUAL TABLET 0 4 New Strength
64980032802 ERYTHROMYCIN-BENZOYL GEL [Benzamycin] 44 317 New Drug
52652600102 FLEQSUVY 25 MG/5 ML ORAL SUSPENSION 0 3 New Drug
51672530104 FLURANDRENOLIDE 0.05% CREAM (G) [Nolix] 2 23 New Drug, Delivery Form and Strength
45802092803 FLURANDRENOLIDE 0.05% LOTION [Nolix] 1 19 New Drug, Delivery Form and Strength
00093751731 FLUTICASONE-SALMETEROL 100-50 INHALER [Advair] 16 160 New Drug and Strength
00093751831 FLUTICASONE-SALMETEROL 250-50 INHALER [Advair] 16 160 New Drug and Strength
00093751631 FLUTICASONE-SALMETEROL 500-50 INHALER [Advair] 16 160 New Drug and Strength
00904717761 FUROSEMIDE 20 MG TABLET [Lasix] 63 403 New Manufacturer and Strength
72887016003 GLYCOPYRROLATE 1.5 MG TABLET [Glycate] 13 44 New Drug
72065014011 GVOKE 1 MG/0.2 ML KIT VIAL 44 320 New Packaging
73154005060 IBSRELA 50 MG TABLET 1 6 New Drug
51991034906 LACOSAMIDE 100 MG TABLET [Vimpat] 58 355 New Drug and Strength
51991035006 LACOSAMIDE 150 MG TABLET [Vimpat] 51 338 New Drug and Strength
51991035106 LACOSAMIDE 200 MG TABLET [Vimpat] 51 338 New Drug and Strength
51991034806 LACOSAMIDE 50 MG TABLET [Vimpat] 63 399 New Drug and Strength
00480124328 LENALIDOMIDE 10 MG CAPSULE [Revlimid] 54 362 New Drug and Strength
00480124421 LENALIDOMIDE 15 MG CAPSULE [Revlimid] 54 362 New Drug and Strength
00480124621 LENALIDOMIDE 25 MG CAPSULE [Revlimid] 54 362 New Drug and Strength
00480124228 LENALIDOMIDE 5 MG CAPSULE [Revlimid] 54 362 New Drug and Strength
15370018060 LOFENA 25 MG TABLET 2 16 New Drug
43386037132 MERZEE 1 MG-20 MCG CAPSULE [Taytulla] 13 137 New Drug
71741002090 NIACIN 500 MG TABLET [Niacor] 17 146 New Manufacturer and Strength
69751010012 PHEXXI 1.8-1-0.4% VAGINAL GEL/PF APP 2 39 New Drug
71334021020 PYRUKYND 20 MG TABLET 5 63 New Drug and Strength
71334022512 PYRUKYND 20-5 MG TAPER PACK TABLET DS PK 5 63 New Drug and Strength
71334020505 PYRUKYND 5 MG TABLET 5 63 New Drug and Strength
71334022011 PYRUKYND 5 MG TAPER PACK TABLET 5 63 New Drug and Strength
71334021550 PYRUKYND 50 MG TABLET 5 63 New Drug and Strength
71334023013 PYRUKYND 50-20 MG TAPER PACK TABLET DS PK 5 63 New Drug and Strength
49281056458 QUADRACEL DTAP-IPV VIAL 63 399 New Drug
42806051330 QUINIDINE SULFATE 200 MG TABLET 63 403 New Drug
42806051230 QUINIDINE SULFATE 300 MG TABLET [Quinora] 63 403 New Drug
49702026055 SELZENTRY 20 MG/ML ORAL SOLUTION 63 403 New Delivery Form and Strength
73502078607 SOAANZ 20 MG TABLET 15 41 New Drug and Strength
73502058610 SOAANZ 40 MG TABLET 4 17 New Drug and Strength
73502068713 SOAANZ 60 MG TABLET 4 17 New Drug and Strength
42806075760 SULFADIAZINE 500 MG TABLET 63 403 New Drug
49884076854 TOLVAPTAN 15 MG TABLET [Samsca] 26 125 New Manufacturer
49884077054 TOLVAPTAN 30 MG TABLET [Samsca] 32 153 New Manufacturer
00310080060 TUDORZA PRESSAIR, INH PDR 400MCG Powder Metered Dose Inhaler 60 Metered Doses 0 18 New Packaging
78206017401 VYTORIN 10-10 MG TABLET 2 0 New Drug and Strength
78206017501 VYTORIN 10-20 MG TABLET 2 0 New Drug and Strength
78206017601 VYTORIN 10-40 MG TABLET 2 0 New Drug and Strength
78206017701 VYTORIN 10-80 MG TABLET 2 0 New Drug and Strength
80644001302 ZEGALOGUE 0.6 MG/0.6 ML SYRINGE 2 109 New Drug and Strength
80644001202 ZEGALOGUE 0.6 MG/0.6ML AUTO INJCT 2 109 New Drug and Strength
78206017801 ZETIA 10 MG TABLET 2 4 New Drug
78206018001 ZOCOR 10 MG TABLET 2 1 New Drug and Strength
78206018101 ZOCOR 20 MG TABLET 2 1 New Drug and Strength
78206018201 ZOCOR 40 MG TABLET 2 1 New Drug and Strength




Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, October 2012, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
May 2023, August 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com



© Q1Group LLC 2005 - 2023  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.